Long EF - Search Results

1

Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States.

Song DL, Altice FL, Copenhaver MM, Long EF. Song DL, et al. Among authors: long ef. PLoS One. 2015 Feb 6;10(2):e0116694. doi: 10.1371/journal.pone.0116694. eCollection 2015. PLoS One. 2015. PMID: 25658949 Free PMC article.

2

The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling.

Zelenev A, Long E, Bazazi AR, Kamarulzaman A, Altice FL. Zelenev A, et al. Int J Drug Policy. 2016 Nov;37:98-106. doi: 10.1016/j.drugpo.2016.08.008. Epub 2016 Sep 15. Int J Drug Policy. 2016. PMID: 27639995 Free PMC article.

3

HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis.

Long EF. Long EF. PLoS One. 2011;6(11):e27625. doi: 10.1371/journal.pone.0027625. Epub 2011 Nov 16. PLoS One. 2011. PMID: 22110698 Free PMC article.

4

Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom.

Long EF, Mandalia R, Mandalia S, Alistar SS, Beck EJ, Brandeau ML. Long EF, et al. PLoS One. 2014 Apr 24;9(4):e95735. doi: 10.1371/journal.pone.0095735. eCollection 2014. PLoS One. 2014. PMID: 24763373 Free PMC article.

5

Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa.

Gilbert JA, Long EF, Brooks RP, Friedland GH, Moll AP, Townsend JP, Galvani AP, Shenoi SV. Gilbert JA, et al. Among authors: long ef. PLoS One. 2015 May 4;10(5):e0126267. doi: 10.1371/journal.pone.0126267. eCollection 2015. PLoS One. 2015. PMID: 25938501 Free PMC article.

6

The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.

Long EF, Brandeau ML, Owens DK. Long EF, et al. Ann Intern Med. 2010 Dec 21;153(12):778-89. doi: 10.7326/0003-4819-153-12-201012210-00004. Ann Intern Med. 2010. PMID: 21173412 Free PMC article.

7

Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Long EF, Stavert RR. Long EF, et al. J Gen Intern Med. 2013 Oct;28(10):1294-301. doi: 10.1007/s11606-013-2417-1. Epub 2013 Apr 16. J Gen Intern Med. 2013. PMID: 23588668 Free PMC article.

8

Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana.

VanDeusen A, Paintsil E, Agyarko-Poku T, Long EF. VanDeusen A, et al. Among authors: long ef. BMC Infect Dis. 2015 Mar 18;15:130. doi: 10.1186/s12879-015-0859-2. BMC Infect Dis. 2015. PMID: 25887574 Free PMC article.

9

The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Long EF, Owens DK. Long EF, et al. Vaccine. 2011 Aug 18;29(36):6113-24. doi: 10.1016/j.vaccine.2011.04.013. Epub 2011 Apr 19. Vaccine. 2011. PMID: 21510996 Free PMC article.

10

Potential population health outcomes and expenditures of HIV vaccination strategies in the United States.

Long EF, Brandeau ML, Owens DK. Long EF, et al. Vaccine. 2009 Aug 27;27(39):5402-10. doi: 10.1016/j.vaccine.2009.06.063. Epub 2009 Jul 8. Vaccine. 2009. PMID: 19591796 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters